Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mooi

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Journal of Bacteriology|August 5, 2004
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990sLeo M Schouls, Han G J van der Heide, Luc Vauterin, et al.
Infection and Immunity|February 20, 1999
Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tractB M van den Berg, H Beekhuizen, R J Willems, et al.
Proceedings. Biological Sciences|July 29, 2005
Pathogen adaptation under imperfect vaccination: implications for pertussisMichiel van Boven, Frits R Mooi, Joop F P Schellekens, et al.
Scandinavian Journal of Infectious Diseases|May 14, 2011
Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009Habib Bokhari, Fahad Said, Muhammad A Syed, et al.
The Journal of Infectious Diseases|March 9, 1999
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated populationI H van Loo, H G van der Heide, N J Nagelkerke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinasesW L Hazenbos, B M van den Berg, C W Geuijen, et al.
Emerging Infectious Diseases|February 18, 2005
Bordetella pertussis isolates, FinlandJohanna Mäkinen, Jussi Mertsola, Frits R Mooi, et al.
Infection and Immunity|May 9, 1998
Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussisC A Geuijen, R J Willems, P Hoogerhout, et al.
Vaccine|October 1, 2013
Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategiesAnna K Lugnér, Nicoline van der Maas, Michiel van Boven, et al.
Protein Expression and Purification|April 2, 2005
The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coliMarcel Hijnen, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Journal of Bacteriology|August 5, 2004
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990sLeo M Schouls, Han G J van der Heide, Luc Vauterin, et al.
Infection and Immunity|February 20, 1999
Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tractB M van den Berg, H Beekhuizen, R J Willems, et al.
Proceedings. Biological Sciences|July 29, 2005
Pathogen adaptation under imperfect vaccination: implications for pertussisMichiel van Boven, Frits R Mooi, Joop F P Schellekens, et al.
Scandinavian Journal of Infectious Diseases|May 14, 2011
Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009Habib Bokhari, Fahad Said, Muhammad A Syed, et al.
The Journal of Infectious Diseases|March 9, 1999
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated populationI H van Loo, H G van der Heide, N J Nagelkerke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinasesW L Hazenbos, B M van den Berg, C W Geuijen, et al.
Emerging Infectious Diseases|February 18, 2005
Bordetella pertussis isolates, FinlandJohanna Mäkinen, Jussi Mertsola, Frits R Mooi, et al.
Infection and Immunity|May 9, 1998
Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussisC A Geuijen, R J Willems, P Hoogerhout, et al.
Vaccine|October 1, 2013
Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategiesAnna K Lugnér, Nicoline van der Maas, Michiel van Boven, et al.
Protein Expression and Purification|April 2, 2005
The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coliMarcel Hijnen, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Pageof 17